Reducing malaria related child mortality in Uganda: defining a sustainable community self-management program:
In Uganda, it is estimated that more than 39,000 children less than five years of age die annually from malaria. Evidence suggests that over 50% of households purchase their drugs from unregulated drug vendors, which are often of questionable quality and/or incorrect dose and quantity. In partnership with Ugandan researchers, a community-based self-management intervention is being proposed to improve the practice of unregulated drug vendors and increase health literacy among caregivers. By focusing on improved access and use of antimalarial, this project’s aims are well aligns with the current UBC Neglected Global Disease.
Kishor Wasan & Jocelyn Conway
Review of Pediatric Medicines in Lower-Middle Income Countries and Adverse Clinical Outcomes:
The World Health Organization is funding a collaboration with the Neglected Global Diseases Initiative and the University of California San Francisco.
This short term contract is the first outcome from a visit from the WHO co-sponsored by the NGDI in August, 2010 by Dr. Clive Ondari, Coordinator of Medicines Access and Rational Use clinical team. Dr. Lisa Bero, Professor, Department of Clinical Pharmacy, School of Pharmacy and Co-Director, San Francisco Branch United States Cochrane Center.
The review will answer the questions:
•What is the extent of poor quality pediatric medicines, as measured by failure to adhere to quality standards?
•Are poor quality standards associated with a particular level in the distribution channel (or other characteristics)?
The draft report is due by the end of March, 2012.